Page 118 - Clinical Laboratory Automation How To Achieve An Automated Utopia For Your Lab Selectscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical laboratory automation how to achieve an automated utopia for your lab selectscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Laboratory Automation How To Achieve An Automated Utopia For Your Lab Selectscience Today - Breaking & Trending Today

Strategic Funding to advance Drug Candidate

Strategic Funding to advance Drug Candidate
Jan 14 2021 Read 170 Times
Biologics manufacturer eleva GmbH has secured up to EUR 60 million in funding from Zukunftsfonds Heilbronn (ZFHN). The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further investment from venture capitalists and/or pharmaceutical companies. The company also announced the addition of Dr. Ralf Smit to its Executive Board.
The Freiburg-based company developed its moss-based platform to produce biologics like antibodies, replacement enzymes, or fusion toxins. The funding from ZFHN, an investor in local start-ups, will is now providing help take CPV-101, a potentially game-changing complement regulator, to more advanced clinical stages and further investments This will enable additional investment on the path to approval. ....

Ralf Smit , Zukunftsfonds Heilbronn , Andreas Schaaf , Business Development , Chief Business Officer , ரால்ஃப் ஸ்மீட் , ஆண்ட்ரியாஸ் ஶாஃப் , வணிக வளர்ச்சி , தலைமை வணிக அதிகாரி ,

Relay Medical Corp.: Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results For COVID-19 Treatment Candidate Based On Its MyCell Technology

(2)
Glow LifeTech has the exclusive rights for MyCell Technology in the United States, Canada and Mexico for one of the primary ingredients used in ArtemiC, a COVID-19 Treatment Candidate with successful Phase II Clinical Results
The formulation statistically significantly improved the clinical recovery of COVID-19 patients in the treatment group in comparison with placebo and 100% of the patients in the treatment group fully recovered within 15 days
Positive results from a phase II double blind randomized controlled clinical trial show the MyCell Technology ArtemiC formulation, successfully met the primary and secondary endpoints for safety and efficacy
1
ArtemiC is a natural anti-inflammatory formulation by Glow partner Swiss PharmaCan and MGC Pharma, intended to suppress cytokine storm and clinical deterioration prevention to support the recovery of COVID-19 patients ....

United States , W Clark Kent , Clark Kent , Bernhard Langer , Relay Medical Corp , Glow Mycell Technology , Glow Lifetech Ltd , Pharmaceuticals Ltd , Mycell Technology Artemi , Swiss Pharmacan Ag Micelle Technology , Mycell Technology , Micelle Technology , Placebo Group , Canadian Securities Exchange , Ateba Resources Inc , Glow Lifetech , Mycell Technology Artemic , Swiss Pharmacan , North American , Boswellia Serrata , Chief Executive Officer , North America , With Glow , Managing Director , Ateba Resources , Medi Cal ,

New Approach for Anti-fibrotic Therapy for Glaucoma Labmate Online

Jan 14 2021 Read 266 Times
University of Birmingham (UK) scientists have shown that a novel low molecular weight dextran-sulphate, ILB® could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease, affecting over 70 million people worldwide, by lowering increased intraocular pressure (IOP) within the eye’s main fluid drainage site.,
OAG develops slowly over many years, leading to excessive matrix deposition (fibrosis), which in turn can lead to increased intraocular pressure (IOP), causing damage to the optic nerve and blindness.
The research has shown that that ILB can normalise matrix deposition inside the eye in a pre-clinical model used to mimic these aspects of human glaucoma, paving the way for new anti-fibrotic therapies to be developed for the disease. ....

Imran Masood , Hannah Botfield , Lisa Hill , University Healthcare Technologies Institute , Institute Of Clinical Sciences , University Of Birmingham United Kingdom , Institute Of Inflammation , United Kingdom , Transforming Growth Factor , Clinical Sciences , West Birmingham , Professor Liam Grover , Healthcare Technologies Institute , இம்ரான் மசூட் , லிசா மலை , பல்கலைக்கழகம் சுகாதாரம் தொழில்நுட்பங்கள் நிறுவனம் , நிறுவனம் ஆஃப் மருத்துவ அறிவியல் , பல்கலைக்கழகம் ஆஃப் பர்மிங்காம் ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது கிஂக்டம் , மாற்றும் வளர்ச்சி காரணி , மருத்துவ அறிவியல் , மேற்கு பர்மிங்காம் , ப்ரொஃபெஸர் லியாம் தோப்பு , சுகாதாரம் தொழில்நுட்பங்கள் நிறுவனம் ,

Welcome To IANS Live - LatestNews - Centre disapproves administration of Covaxin to those below 18 yrs

A le ....

New Delhi , News Service , India Private , Bharat Biotech , Drugs Controller General , All Rights , புதியது டெல்ஹி , செய்தி சேவை , இந்தியா ப்ரைவேட் , பாரத் பயோடெக் , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , அனைத்தும் உரிமைகள் , தடுப்பு மருந்துகள் ,

NeonMind Biosciences Inc: NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials

NeonMind Biosciences Inc: NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials
NeonMind Biosciences Inc. (
CSE: NEON) (
NeonMind ) a company conducting research into the potentially therapeutic uses of compounds found in psychedelic mushrooms, is pleased to announce that it has added Frank Russo as an advisor and consultant to assist the Company in selecting or developing music playlists for its clinical trials or for use with treatments to support optimum mental health.
NeonMind Engages Music Expert Dr. Frank Russo
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7646/72039 img1a.jpg ....

United Kingdom , British Columbia , Frank Russo , Canadian Psychological Association , Exvera Communications Inc , Massey College , University Of Toronto Music , Psychology At Ryerson University , Mcmaster Institute For Music , Science Of Music Auditory Research , Canadian Acoustical Association , University Of British Columbia , Canadian Securities Exchange , Toronto Rehabilitation Institute , Lab At Ryerson , Edge Communications , British Columbia Newsfile Corp , Health Collaboratory Ma , Neonmind Biosciences Inc , Health Canada , Mind Biosciences , Mcmaster Institute , Health Collaboratory , Music Auditory Research , Canadian Acoustical , Penny White ,